PHARMACIE PONSARD : revenue, balance sheet and financial ratios

PHARMACIE PONSARD is a French company founded 16 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75016), this company of category PME shows in 2016 a revenue of 2.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE PONSARD (SIREN 518990718)
Indicator 2020 2019 2016 2015 2014 2013 2012
Revenue N/C N/C 2 929 176 € 2 906 887 € 2 521 391 € 2 279 913 € 1 826 294 €
Net income 362 627 € 485 624 € 198 916 € 183 151 € 131 367 € 134 824 € 18 799 €
EBITDA N/C N/C 311 726 € 297 563 € 233 315 € 208 055 € 87 358 €
Net margin N/C N/C 6.8% 6.3% 5.2% 5.9% 1.0%

Revenue and income statement

In 2020, PHARMACIE PONSARD generates positive net income of 363 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2012-2020: 19 k€ -> 363 k€.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

362 627 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 610%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

609.51%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

12.047%

Asset age ratio (2020) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

2.0%

Solvency indicators evolution
PHARMACIE PONSARD

Sector positioning

Debt ratio
609.51 2020
2016
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Average

In 2020, the debt ratio of PHARMACIE PONSARD (609.51) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
12.05% 2020
2016
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Watch

In 2020, the financial autonomy of PHARMACIE PONSARD (12.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
9.33 years 2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Average

In 2016, the repayment capacity of PHARMACIE PONSARD (9.33) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 224.62. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

224.618

Liquidity indicators evolution
PHARMACIE PONSARD

Sector positioning

Liquidity ratio
224.62 2020
2016
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Good

In 2020, the liquidity ratio of PHARMACIE PONSARD (224.62) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
18.69x 2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.32x
Good

In 2016, the interest coverage of PHARMACIE PONSARD (18.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 438 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 473 days. Excellent situation: suppliers finance 35 days of the operating cycle (retail model).

Operating WCR (2020) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2020) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

438 j

Supplier credit (2020) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

473 j

Inventory turnover (2020) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE PONSARD

Positioning of PHARMACIE PONSARD in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 180 transactions of similar company sales in 2020, the value of PHARMACIE PONSARD is estimated at 5 124 883 € (range 3 417 200€ - 6 914 851€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
3417k€ 5124k€ 6914k€
5 124 883 € Range: 3 417 200€ - 6 914 851€
NAF 5 année 2020

Valuation method used

Net Income Multiple
362 627 € × 14.1x = 5 124 884 €
Range: 3 417 200€ - 6 914 851€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE PONSARD with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE PONSARD

What is the revenue of PHARMACIE PONSARD ?

The revenue of PHARMACIE PONSARD in 2016 is 2.9 M€.

Is PHARMACIE PONSARD profitable?

Yes, PHARMACIE PONSARD generated a net profit of 363 k€ in 2020.

Where is the headquarters of PHARMACIE PONSARD ?

The headquarters of PHARMACIE PONSARD is located in PARIS (75016), in the department Paris.

Where to find the tax return of PHARMACIE PONSARD ?

The tax return of PHARMACIE PONSARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE PONSARD operate?

PHARMACIE PONSARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.